Finaflex PX Pro Xanthine 30 Servings
Finaflex's PX Pro Xanthine is the ultimate in weight loss. PX Pro Xanthine is made with the highest quality ingredients and patent pending ingredients to promote fat loss, enhanced focus, appetite suppression, and hours of clean long lasting energy.
Finaflex PX Pro Xanthine Powder Product Highlights
- The Original Super Thermogenic
- Supports Appetite Suppression
- Promotes Enhanced Focus
- Provides Hours and Hours of Clean Energy
- Made with the Highest Quality Ingredients
How Much Caffeine is in Finaflex PX Pro Xanthine?
PX Pro Xanthine contains 200mg caffeine per serving.
Mix 1 scoop with 6-8 ounces of water 1-2 times daily.
Finaflex PX Pro Xanthine Powder 30 Servings Supplement Facts
Serving Size: 1 Scoop (4g)
Servings Per Container: 30
Vitamin C (as Ascorbic Acid 1,000mg
Antioxidant Energy Matrix 453mg
Caffeine, IrisinXD, [Green Tea LEaf Extract (Camelia sinensis) (Std min 60% EGCG), Cocoa (Theobroma cacao) Seed Extract), Blueberry Powder, Theobromine, Theacrine (as Tea Crine), Rauwolfia vomitoria Extract (Root Bar)
Mood Support 115mg
L-Phenylalanine, Schisandra chinensis Extract (berry), Guayausa Extract (llex guayusa) (leaf) Huperzia Serrata Extract (Club Moss
Store in a cool dry place after opening. Do not exceed recommended dosage.
Whyte AR, Cheng N, Fromentin E, Williams CM. A Randomized, Double-Blinded, Placebo-Controlled Study to Compare the Safety and Efficacy of Low Dose Enhanced Wild Blueberry Powder and Wild Blueberry Extract (ThinkBlue™) in Maintenance of Episodic and Working Memory in Older Adults. Nutrients. 2018;10(6):660. Published 2018 May 23. doi:10.3390/nu10060660
Kuhman DJ, Joyner KJ, Bloomer RJ. Cognitive Performance and Mood Following Ingestion of a Theacrine-Containing Dietary Supplement, Caffeine, or Placebo by Young Men and Women. Nutrients. 2015 Nov 19;7(11):9618-32. doi: 10.3390/nu7115484. PMID: 26610558; PMCID: PMC4663612.
Bisong S, Brown R, Osim E. Comparative effects of Rauwolfia vomitoria and chlorpromazine on social behaviour and pain. N Am J Med Sci. 2011;3(1):48-54. doi:10.4297/najms.2011.348